XML 55 R39.htm IDEA: XBRL DOCUMENT v3.24.2
Long-Term Investment (Tables)
 12 Months Ended
Mar. 31, 2024
Long-Term Investment [Abstract]  
Schedule of Long-Term Investment Long-term investment consists of the following:
   March 31,
2024		   March 31,
2023		 
Kahamadi Bio (1)  $
-
   $
-
 
Zhuoli Life (2)   
-
    1,680,337 
Songlu Pharmaceutical (3)   83,099    87,367 
Jiuzhou Digital (4)   4,155    4,368 
Guoshu Lianren (Zhejiang) Medical and Health Management Co., Ltd (5)   1,108,007    
-
 
Long-term investment  $1,195,261   $1,772,072 
(1) It represents 49% investment in Kahamadi Bio. The investment is recorded using the equity method. Kahamadi Bio suffered loss of $0 and $0 in the year ended March 31, 2024 and 2023.
(2) It represents 39% investment in Zhejiang Zhuoli Life Service Co., LTD (“Zhuoli Service”), formerly known as Zhejiang Zhetong Medical Co., Ltd. Zhuoli Service was established in March 2020 to target potential acquisitions or to cooperate with local pharmacies. By attracting more funds from local investors, the Company expects to continue growing its local network in the future. In the year ended March 31, 2021, Jiuzhou Pharmacy injected funds of approximately $1,443,752 into Zhuoli Service. The investment is recorded using the equity method. Zhuoli Service suffered loss of $2,402,376 in the year ended March 31, 2023. An impairment loss of $1,607,537 was recorded in the year ended March 31, 2024. After the impairment, the carrying amount of Zhuoli Service was nil.
(3) It represents 0.37% investment in Inner Mongolia Songlu Pharmaceutical Co. (“Songlu Pharmaceutical”). The investment is recorded based on cost method.
(4) It represents 25.92% investment in Zhejiang Jiuzhou Digital Medicine Technology Co., LTD. In the year ended March 31, 2023, Jiuzhou Pharmacy injected funds of approximately $4,379 into Jiuzhou Digital. The investment is recorded based on equity method.
(5) It represents 8% investment in Guoshu Lianren (Zhejiang) Medical and Health Management Co., Ltd. In the year ended March 31, 2024, Jiuzhou Pharmacy injected funds of approximately $1,113,650(RMB 8,000,000) into Guoshu Lianren (Zhejiang) Medical and Health Management Co., Ltd. The investment is recorded based on equity method.